{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:48:01Z","timestamp":1790750881104,"version":"4.1.0"},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,2]]},"DOI":"10.1093\/rheumatology\/keab756","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T20:40:14Z","timestamp":1633639214000},"page":"865-867","source":"Crossref","is-referenced-by-count":48,"title":["Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1649-3175","authenticated-orcid":false,"given":"Camille","family":"Mettler","sequence":"first","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, D\u00e9partement de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence National pour les Maladies Auto-Immunes Syst\u00e9miques Rares, H\u00f4pital Cochin, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2635-3360","authenticated-orcid":false,"given":"Annie-Pierre","family":"Jonville-Bera","sequence":"additional","affiliation":[{"name":"Centre R\u00e9gional de Pharmacovigilance, Members of the French Pharmacovigilance Network, CHRU de Tours, H\u00f4pital Bretonneau, Tours"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-6975","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Grandvuillemin","sequence":"additional","affiliation":[{"name":"Centre R\u00e9gional de Pharmacovigilance, Members of the French Pharmacovigilance Network, Centre Hospitalier Universitaire, Dijon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2045-4742","authenticated-orcid":false,"given":"Jean-Marc","family":"Treluyer","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, D\u00e9partement de Pharmacologie, Centre R\u00e9gional de Pharmacovigilance, Members of the French Pharmacovigilance Network, H\u00f4pital Cochin"},{"name":"Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6612-7336","authenticated-orcid":false,"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, D\u00e9partement de M\u00e9decine Interne, Centre de R\u00e9f\u00e9rence National pour les Maladies Auto-Immunes Syst\u00e9miques Rares, H\u00f4pital Cochin, Paris"},{"name":"Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-3571","authenticated-orcid":false,"given":"Laurent","family":"Chouchana","sequence":"additional","affiliation":[{"name":"Assistance Publique-H\u00f4pitaux de Paris, D\u00e9partement de Pharmacologie, Centre R\u00e9gional de Pharmacovigilance, Members of the French Pharmacovigilance Network, H\u00f4pital Cochin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"2022020819092161600_keab756-B1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","article-title":"Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Commentary","volume":"72","author":"Montastruc","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"2022020819092161600_keab756-B2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2022020819092161600_keab756-B3","doi-asserted-by":"crossref","first-page":"102732","DOI":"10.1016\/j.autrev.2020.102732","article-title":"Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review","volume":"20","author":"Liozon","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2022020819092161600_keab756-B4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines"},{"key":"2022020819092161600_keab756-B5","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/S2665-9913(21)00108-9","article-title":"Flare of rheumatoid arthritis after COVID-19 vaccination","volume":"3","author":"Terracina","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2022020819092161600_keab756-B6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/rheumatology\/keg116","article-title":"Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment","volume":"42","author":"Nordborg","year":"2003","journal-title":"Rheumatology"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab756\/40995169\/keab756.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/2\/865\/42368837\/keab756.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/2\/865\/42368837\/keab756.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T14:11:29Z","timestamp":1644329489000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/2\/865\/6385249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":6,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,10,9]]},"published-print":{"date-parts":[[2022,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab756","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,10,9]]}}}